Live from the NIH registry
Studies recruiting near College Station right now
Top 25 of 47 recruiting studies, sorted by proximity — each links to its official registry page
TREC@TAMU Cancer Prevention Registry and Repository
Cancer, Genetics
N/A
Observational 2,500 participants sought
Texas A&M Family Care — Bryan, Texas (7.6 mi)
· Sponsor: Texas A&M University
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
Saint Joseph Regional Cancer Center — Bryan, Texas (7.6 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Malignancy
N/A
Observational 240 participants sought
Saint Joseph Regional Cancer Center — Bryan, Texas (7.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Virtual Walking Intervention for Neuropathic Pain in Spinal Cord Injury
Spinal Cord Injuries, Neuropathic Pain
N/A
Interventional 250 participants sought
Texas A&M University — College Station, Texas (3.7 mi)
· Sponsor: Texas A&M University
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Solid Tumors
Phase 2
Interventional 450 participants sought
USA13-0 — Anderson, Texas (19.6 mi)
· Sponsor: DualityBio Inc.
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Cardiotoxicity, HER2/Neu Positive
Phase 3
Interventional 491 participants sought
Saint Joseph Regional Cancer Center — Bryan, Texas (7.6 mi)
· Sponsor: SWOG Cancer Research Network
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Advanced Prostate Cancer, Metastatic Prostate Cancer
Phase 1
Interventional 210 participants sought
SCRI Oncology Partners — Nashville, Texas (26.9 mi)
· Sponsor: Genentech, Inc.
Interprofessional Pharmacogenomics (IPGx) Registry and Repository
Diabetes, Cholesterol
N/A
Observational 3,000 participants sought
Texas A&M Family Care — Bryan, Texas (7.6 mi)
· Sponsor: Texas A&M University
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Saint Joseph Regional Cancer Center — Bryan, Texas (7.6 mi)
· Sponsor: SWOG Cancer Research Network
IPGx PILOT Whole Genome Sequencing Extension Cohort
Adverse Drug Reaction (ADR), Polypharmacy Patients
N/A
Observational 50 participants sought
Texas A&M Family Care — Bryan, Texas (7.6 mi)
· Sponsor: Texas A&M University
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Metastatic Small Intestinal Adenocarcinoma, Stage III Small Intestinal Adenocarcinoma AJCC v8
Phase 2
Interventional 94 participants sought
Saint Joseph Regional Cancer Center — Bryan, Texas (7.6 mi)
· Sponsor: SWOG Cancer Research Network
A Clinical Study of YL205 in Patients With Advanced Solid Tumors
Advanced Solid Tumors
Phase 1, Phase 2
Interventional 252 participants sought
Sarah Cannon Research (SCRI)-Tennessee — Nashville, Texas (26.9 mi)
· Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,000 participants sought
Saint Joseph Regional Cancer Center — Bryan, Texas (7.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma
Phase 3
Interventional 1,450 participants sought
Saint Joseph Regional Cancer Center — Bryan, Texas (7.6 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Lean Beef as Part of a Healthy Meal Plan in Adolescents With Polycystic Ovary Syndrome (PCOS)/Polyendocrine Metabolic Ovarian Syndrome (PMOS)
PCOS (Polycystic Ovary Syndrome), Obese Adolescents
N/A
Interventional 36 participants sought
Texas A&M AgriLife — College Station, Texas (3.7 mi)
· Sponsor: Texas A&M University
Lutein, Zeaxathin, and Fish Oil Supplementation
Cognitive Performance, Age-Related Macular Degeneration
N/A
Interventional 80 participants sought
Gilchrist Building — College Station, Texas (3.7 mi)
· Sponsor: Texas A&M University
Effect of Sage Extract Supplementation on Cognitive Function in Middle-Aged Men and Women
Cognitive Ability, General
N/A
Interventional 64 participants sought
Exercise & Sport Nutrition Lab - Texas A&M University — College Station, Texas (3.7 mi)
· Sponsor: ESM Technologies, LLC
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
N/A
Observational 8,000 participants sought
Baylor Scott & White College Station Hospital — College Station, Texas (3.7 mi)
· Sponsor: Stryker Instruments
Prandial Metabolic Phenotyping in Sarcopenic Older Adults Comparing Plant Based and Whey Based Protein
Protein Metabolism
N/A
Interventional 100 participants sought
Texas A&M University - CTRAL — College Station, Texas (3.7 mi)
· Sponsor: Texas A&M University
The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.
Cancer
N/A
Observational 10,000 participants sought
Baylor Scott & White Medical Center - College Station — College Station, Texas (3.7 mi)
· Sponsor: Baylor Research Institute
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Pancreatic Acinar Cell Carcinoma, Pancreatic Adenosquamous Carcinoma
Phase 2
Interventional 152 participants sought
Saint Joseph Regional Cancer Center — Bryan, Texas (7.6 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Multiple conditions
Phase 2
Interventional 314 participants sought
Saint Joseph Regional Cancer Center — Bryan, Texas (7.6 mi)
· Sponsor: National Cancer Institute (NCI)
An Open-Label Pharmacokinetic Study for Patients With Actinic Keratosis on the Upper Extremities or the Face
Actinic Keratosis (AK)
Phase 1
Interventional 48 participants sought
J&S Studies — College Station, Texas (3.7 mi)
· Sponsor: Sun Pharmaceutical Industries Limited
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Saint Joseph Regional Cancer Center — Bryan, Texas (7.6 mi)
· Sponsor: NRG Oncology
Study Brain Mechanisms of Frustration With Magnetoencephalography in Healthy Volunteers
Irritability
EARLY/Phase 1
Interventional 90 participants sought
Texas A&M University — College Station, Texas (3.7 mi)
· Sponsor: National Institute of Mental Health (NIMH)